Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000336812 | SCV000393358 | uncertain significance | Congenital stationary night blindness 1D | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. |
Eurofins Ntd Llc |
RCV000732305 | SCV000860239 | likely benign | not specified | 2018-03-30 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001522730 | SCV001732325 | benign | not provided | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002520971 | SCV003690025 | uncertain significance | Inborn genetic diseases | 2021-10-21 | criteria provided, single submitter | clinical testing | The c.2183C>T (p.A728V) alteration is located in exon 6 (coding exon 5) of the SLC24A1 gene. This alteration results from a C to T substitution at nucleotide position 2183, causing the alanine (A) at amino acid position 728 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Genome Diagnostics Laboratory, |
RCV001522730 | SCV001807854 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001522730 | SCV001971424 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV003940236 | SCV004750385 | likely benign | SLC24A1-related disorder | 2019-07-19 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |